Canadian researchers found the rate of rare heart inflammation was twofold to threefold higher after receipt of the Moderna vaccine compared with Pfizer, according to an article published on the Center for Infectious Disease Research and Policy’s website.
Read the full post on Becker's Hospital Review - Healthcare News
